Clinitech Laboratory IPO Subscription Status
swati_rathod
Sat, 07/27/2024 – 00:24
Clinitech Laboratory IPO Subscription – Day-2 Subscription at 6.03 Times
Clinitech Laboratory IPO will close on 29 July. Shares of Clinitech Laboratory are likely to be listed on 1 August. Shares of Clinitech Laboratory will make trading debut on BSE SME platform
On 26 July 2024, Clinitech Laboratory IPO received bids for 34,45,200 shares much more than the 5,71,200 shares available. This means that the Clinitech Laboratory IPO was oversubscribed by 6.03 times by the end of the 2nd day.
Employees (N.A.)
HNI / NII (1.33X)
Retail (10.10X)
Total (6.03X)
Clinitech Laboratory IPO subscription was primarily driven by retail investors on the first day, followed by High Net-Worth Individuals (HNIs) and Non-Institutional Investors (NIIs)., QIBs and HNIs/NIIs increase their subscriptions in the final hours of the last day. Overall subscription figures exclude the anchor portion and market-making segment of the IPO.
QIBs are large institutional investors like mutual funds and insurance companies, while HNIs/NIIs are wealthy individuals and smaller institutions.
Here are the subscription details for Clinitech Laboratory IPO as of Day 2:
Investor Category
Subscription (times)
Shares Offered
Shares Bid For
Total Amount (₹ in Crore)
Market Maker
1.00
31,200
31,200
0.30
HNIs / NIIs
1.33
3,01,200
4,02,000
3.86
Retail Investors
10.10
3,01,200
30,43,200
29.21
Total
6.03
5,71,200
34,45,200
33.07
On day 1, Clinitech Laboratory IPO was subscribed 2.61 times. By day 2, the subscription status had risen to 6.03 times. Clinitech Laboratory IPO received good interest. High Net-Worth Individuals (HNIs) and Non-Institutional Investors (NIIs) subscribed 1.33 times, while Retail Investors showed significant interest with a subscription rate of 10.10 times. Overall, the IPO was subscribed 6.03 times till now. Final subscription status will be clear end of day 3.
News
Sat, 07/27/2024 – 01:11
Clinitech Laboratory IPO Subscription Status
Investment/Trading in securities Market is subject to market risk, past performance is not a guarantee of future performance. The risk of loss in trading and investment in Securities markets including Equites and Derivatives can be substantial.
Clinitech Laboratory IPO Subscription Status
swati_rathod
Sat, 07/27/2024 – 00:24
Tanushree Jaiswal
Clinitech Laboratory IPO Subscription – Day-2 Subscription at 6.03 Times
Clinitech Laboratory IPO will close on 29 July. Shares of Clinitech Laboratory are likely to be listed on 1 August. Shares of Clinitech Laboratory will make trading debut on BSE SME platform
On 26 July 2024, Clinitech Laboratory IPO received bids for 34,45,200 shares much more than the 5,71,200 shares available. This means that the Clinitech Laboratory IPO was oversubscribed by 6.03 times by the end of the 2nd day.
Employees (N.A.)
HNI / NII (1.33X)
Retail (10.10X)
Total (6.03X)
Clinitech Laboratory IPO subscription was primarily driven by retail investors on the first day, followed by High Net-Worth Individuals (HNIs) and Non-Institutional Investors (NIIs)., QIBs and HNIs/NIIs increase their subscriptions in the final hours of the last day. Overall subscription figures exclude the anchor portion and market-making segment of the IPO.
QIBs are large institutional investors like mutual funds and insurance companies, while HNIs/NIIs are wealthy individuals and smaller institutions.
Here are the subscription details for Clinitech Laboratory IPO as of Day 2:
Investor Category
Subscription (times)
Shares Offered
Shares Bid For
Total Amount (₹ in Crore)
Market Maker
1.00
31,200
31,200
0.30
HNIs / NIIs
1.33
3,01,200
4,02,000
3.86
Retail Investors
10.10
3,01,200
30,43,200
29.21
Total
6.03
5,71,200
34,45,200
33.07
On day 1, Clinitech Laboratory IPO was subscribed 2.61 times. By day 2, the subscription status had risen to 6.03 times. Clinitech Laboratory IPO received good interest. High Net-Worth Individuals (HNIs) and Non-Institutional Investors (NIIs) subscribed 1.33 times, while Retail Investors showed significant interest with a subscription rate of 10.10 times. Overall, the IPO was subscribed 6.03 times till now. Final subscription status will be clear end of day 3.
IPOs
News
Sat, 07/27/2024 – 01:11
Breadcrumb
Clinitech Laboratory IPO Subscription Status
penny stock url
/news
Clinitech Laboratory IPO Subscription Status
Investment/Trading in securities Market is subject to market risk, past performance is not a guarantee of future performance. The risk of loss in trading and investment in Securities markets including Equites and Derivatives can be substantial.
Meta Title
Clinitech Laboratory IPO Subscription Status
Meta Description
On July 26, 2024, the Clinitech Laboratory IPO received bids for 34,45,200 shares, far surpassing the available 5,71,200 shares. By the end of day two, it was oversubscribed by 6.03 times. Read this news for more insights.
Is in Get Premium
Off
Is In Spotlight
Off
Thumbnail Read More
5paisa
